Literature DB >> 22888291

Genetic variants and haplotypes of the UGT1A9, 1A7 and 1A1 genes in Chinese Han.

Xiaoqing Zhang1, Guokun Ao, Yuewen Wang, Wei Yan, Min Wang, Erfei Chen, Fangfang Yang, Jin Yang.   

Abstract

In this report, we describe combined polymorphisms of the UGT1A9, UGT1A7 and UGT1A1 genes in 100 unrelated, healthy Chinese Han subjects. The functional regions of these genes were sequenced and comprehensively analyzed for genetic polymorphisms. Thirty variants were detected, including five novel forms. Tentative functional predictions indicated that a Cys → Arg substitution at position 277 in the UGT1A7 gene could alter the protein conformation and that 12460T > G in the 3'UTR might influence protein translation through specifically expressed miRNAs. UGT1A9*1b was a major functional variant in the subjects examined whereas the *1f allele had a frequency of only 0.5%. A special functional haplotype (GAGAAC) was identified for UGT1A9, 1A7 and 1A1. These findings provide fundamental genetic information that may serve as a basis for larger studies designed to assess the metabolic phenotypes associated with UGT1A polymorphisms. They also provide important data for the implementation of personalized medicine in Chinese Han.

Entities:  

Keywords:  Chinese Han; UGT1A; genetic polymorphisms; haplotype

Year:  2012        PMID: 22888291      PMCID: PMC3389530          DOI: 10.1590/S1415-47572012005000036

Source DB:  PubMed          Journal:  Genet Mol Biol        ISSN: 1415-4757            Impact factor:   1.771


UDP-glucuronosyltransferases (UGTs) are important enzymes in glucuronidation, the major pathway for the removal of endogenous compounds and potentially toxic chemicals ingested in the diet (King ; Chu ). UGT1A9 (MIM# 606434), UGT1A7 (MIM# 606432) and UGT1A1 (MIM# 191740) are three important members of the UGT1A subfamily that form a gene cluster on chromosome 2q37 (Miners ; Cecchin ). Each isoform comprises a unique alternate exon 1 that is regulated by its own promoter and is linked to the same four downstream exons as the other isoforms (Gong ). The enzyme activities of UGT1A9, 1A7 and 1A1 show wide interindividual variability that can lead to the failure of drug therapy, severe drug toxicity or unpredictable adverse side effects. Major mutations in the UGT1A1 gene can cause a serious metabolic deficiency in bilirubin that leads to a condition known as Gilbert’s syndrome. The missense mutation 211G > A (UGT1A1*6 allele) markedly attenuates (to <10% of normal) or completely abolishes enzyme activity (Tukey and Strassburg, 2000; Verlaan ) and reduces activity towards 7-ethyl-10-hydroxy-camptothecin (SN-38) (Huang ). UGT1A7 and UGT1A9 also contribute to SN-38 glucuronidation (Gagné ; Villeneuve ). The relative Vmax of the UGT1A7*3 allele is 5.8-fold lower than the wild-type and confers a slow glucuronidation phenotype (Guillemette ). Genetic polymorphisms that alter enzyme functions are of clinical value in predicting a predisposition to disease and an individual’s ability to respond to certain therapeutic agents (Evans and Johnson, 2001). Haplotypes that combine variants of more than one gene can be used to investigate genotype-phenotype associations (Clark, 2004; Kitsios and Zintzaras, 2009). The co-occurrence of single nucleotide polymorphisms (SNPs) or segmental haplotypes with functional changes in UGT1A9, 1A7 and 1A1 can result in altered glucuronidation activity (Judson ). In this study, we used direct sequencing to screen UGT1A9, 1A7 and 1A1 for genetic polymorphisms in their exons, promoters and surrounding introns and inferred the haplotype structures of each region. The subjects consisted of 100 Chinese Han (50 males and 50 females, 18–40 years old) from Yulin. All of the participants were in a healthy condition based on physical examination and their medical histories. The aim of the investigation and the procedures involved were explained to the volunteers, all of whom provided written informed consent before participating in the study. The project was reviewed and approved by the Ethics Committee of Northwest University. Blood samples were obtained from all participants and genomic DNA was isolated from peripheral blood leukocytes by a standard procedure (Okuda ). Polymerase chain reaction (PCR) amplifications were done using 14 sets of primers. DNA sequencing reactions were done using ABI PRISM Big Dye Terminator V3.1 cycle sequencing chemistry. The sequences of the PCR and sequencing primers are available upon request. Sequencher 4.10.1 software (Gene Codes Corporation, Ann Arbor, MI, USA) was used for base calling, sequence alignment and polymorphism determination based on the DNA sequences. Novel variants were those not listed in the dbSNP database and having no rs record. Haploview 4.2 software (Massachusetts Institute of Technology, Cambridge, MA, USA) was used to estimate minor allele frequencies (MAF), test for Hardy-Weinberg equilibrium (HWE) and analyze linkage disequilibrium (LD) (Barrett ). Polymorphisms in the transcription factor binding site in the promoter region were analyzed using TFSEARCH (Transcription Factor Binding Sites Search) software (Heinemeyer ) and the MAPPER platform (Marinescu ). Two prediction programs, PANTHER (Thomas ; Thomas and Kejariwal, 2004) and PolyPhen (Ramensky ), were used to estimate the possible impact of novel nonsynonymous mutations on protein function by combining structural information and sequence similarity analysis. Swiss-PdbViewer 3.7 (Peitsch ) was used to thread a protein primary sequence onto a three-dimentional template. CASTp was used to identify protein pockets and measure the changes in pocket volume produced by novel amino acid substitutions (Binkowski ). MicroRNA (miRNA) target prediction was done using PITA (Kertesz ), an algorithm that considers site accessibility and hybridization energy to predict potential miRNAs that target UGT1As and harbor novel SNPs in their binding sites. We detected 30 genetic variants, the allele frequencies of which were in Hardy-Weinberg equilibrium (p > 0.05). Eight polymorphisms were found in the common exons region, including five rare sites: 6833G > A, 6893T > C, 7939C > T (Pro364Leu), 12126T > G (Tyr486Asp) and 12460T > G. The novel nucleic acid replacement of G to A at nucleotide 6833 was a synonymous mutation (Lys317Lys) in exon 2. In the specific promoter and exon 1 regions we detected five well-known SNPs for the UGT1A1 gene, seven promoter variants for the UGT1A9 gene including two novel polymorphisms (−2189T > C, 1.5%, and −40 > G, 0.5%), and nine common variants and one novel rare nonsynonymous mutation (829T > C, Cys277Arg) for the UGT1A7 gene. Table 1 summarizes the data for these polymorphisms.
Table 1

Summary of the UGT1A9, 7 and 1 polymorphisms detected in Chinese Han.

LocationNucleotide changeAmino acid changeNumber of subjects
Minor allele frequencyHWE P valueRemark
W/WW/mM/m
1A9 Promoter−2189T > C97300.0151.000novel
−1888T > G91900.0451.000rs6731242
−1819T > C3743200.4150.322rs13418420
−441C > T96400.0201.000rs2741045
−332T > C881110.0650.681rs2741046
−118delT3547180.4150.868rs67695772
−40C > G99100.0051.000novel
1A7 Promoter−543A > G543790.2750.593rs4530361
−341C > T752230.1400.576rs28946877
−57T > G603280.2250.419rs7586110
1A7 Exon133C > APro11Pro5832100.2600.143rs7577677
387T > GAsn129Lys3744190.4140.495rs17868323
391C > AArg131Arg3744190.4140.495rs17863778
392G > AArg131Gln3744190.4140.495rs17868324
622T > CTrp208Arg5436100.2800.378rs11692021
756G > ALeu252Leu762220.1301.000rs17864686
829T > CCys277Arg99100.0051.000novel
1A1 Promoter−364C > T821530.1050.139rs887829
−64G > C95500.0251.000rs873478
−52insTA811720.1050.568rs3064744
1A1 Exon 1211G > AGly71Arg543970.2651.000rs4148323
686C > APro229Gln97300.0151.000rs35350960
1A Exon 26833G > ALys317Lys98200.0101.000novel
1A Intron 26893T > C91900.0451.000rs4148327
1A Exon 47939C > TPro364Leu95500.0251.000rs34946978
1A Exon 512126T > GTyr486Asp97300.0151.000rs34993780
1A 3′UTR12460T > G99100.0051.000novel
12483T > C225730.1451.000rs10929303
12611G > C221770.1301.000rs1042640
12712G > C223750.1351.000rs8330

W – wild-type, M – mutant, HWE – Hardy-Weinberg equilibrium.

Fourteen alleles were identified across the sequencing regions of the UGT1A9, 1A7 and 1A1 genes. There were six well-known alleles located in the promoters that influenced enzyme activity by affecting pre-transcriptional control. Among these alleles, a common SNP rs67695772 (UGT1A9*1b) that leads to a deletion of T at −118 position occurred at a high frequency (41.5%), with a genotype distribution (47 heterozygous and 18 homozygous subjects) similar to that of UGT1A7*2. In contrast, the allele UGT1A9*1f, which combined *1b with three other sites (−1819T > C, −441C > T and −332T > C) in the promoter region of the UGT1A9 gene, showed a very low frequency (0.5%). In the coding regions, four variants (UGT1A7*2, *3, *4 and *11) with a frequency of 25% were found in exon 1 of the UGT1A7 gene while another four variants (UGT1A1*6, *7, *27 and *63) were located in the UGT1A1 gene; the latter variants had relatively low frequencies and none were homozygous. Tables 1 and 2 summarize these findings.
Table 2

Ethnic differences in UGT1A allelic frequencies.

EthnicityNUGT1A1
UGT1A7
UGT1A9
Reference
*6*7*27*28*63*80*81*2*3*4*11*1b*1d*1f
Han10026.51.51.510.52.510.52.541.427.028.041.441.52.00.5This study
Chinese28037.026.325.2Chen et al. (2006)
Dong2739.92.215.3Zhang et al. (2007)
She26412.50.97.8Zhang et al. (2007)
Taiwanese44121.35.028.638.826.8Tang et al. (2005)
Singaporean2417.10.21.718.70.6Zhou et al. (2009)
Japanese30115.30.21.013.00.521.435.066.8Saeki et al. (2006)
Korean5011.01.02.014.014.03.021.039.061.0Yea et al. (2008)
Asian4614.05.018.051.021.722.051.049.0Thomas et al. (2006)
Caucasian920.00.028.641.035.936.041.059.0Thomas et al. (2006)

N – number of subjects in each study.

The pairwise LD for polymorphisms in the UGT1A9, 1A7 and 1A1 genes was expressed as r2 on a graded red scale. Among the variants listed in Table 1, only common SNPs with frequencies >10% were tested for pairwise LD. The LD map is shown in Figure S1a in which increasing color intensity indicates greater linkage. In view of the potential of rare mutations to alter enzyme function all of the variants were included in the LD analyses. As shown in Figure S1b, two main linkage blocks were observed across the locus. Block 1 located in the promoter and exon 1 of the UGT1A7 gene included three complete LD variants (387T > G, 391C > A and 392G > A) that showed the greatest linkage (densest red color). In addition, three polymorphisms in block 2 also had high LD in the 3′-untranslated region (UTR) of the UGT1A1 gene. Haplotype analysis using an accelerated EM algorithm identified two major haplotypes, TCTCGT in block 1 and CCC in block 2 that accounted for 57% and 85.5% of the total haplotype diversity, respectively; four rare haplotypes had a frequency of <5%. The level of recombination between the two blocks was predicted to have a multiallelic D’ value of 0.35. The significant LD seen here among several UGT1A SNPs suggests that it would be possible to use only a small number of highly informative SNP markers as htSNP for genotyping in association studies. Table 3 summarizes the haplotype frequency and htSNP for each LD block.
Table 3

Haplotype analysis of each LD block in 100 Chinese Han subjects.

BlockMarkersHaplotypePopulation frequencyhtSNPs
a−57T > G, 33C > A, 387T > G, 391C > A, 392G > A, 622T > CTCTCGT0.570−57T > G, 33C > A, 387T > G, 622T > C
GAGAAC0.218
TCGAAT0.134
TAGAAC0.037
GCTCGC0.013
GCGAAT0.011

b12483T > C,12611G > C, 12712G > CCCC0.85512483T > C, 12611G > C
TGG0.130
TCC0.010

htSNPs – haplotype tag SNPs.

The TFSEARCH and MAPPER platforms were used to predict the effects that the two novel polymorphisms in the promoter of the UGT1A9 gene would have on the transcription factor binding site. Neither the wild-type nor mutant of the −40C > G variant was predicted to bind to any transcription factor. For the −2189T > C variant, analysis of the E-values revealed some differences between the wild-type and mutant, but neither had a consistent effect on the transcription factor binding site. Further studies are required to determine whether the −2189T > C variant has a role in transcription factor regulation. Ten miRNAs containing the novel polymorphism 12460T>G in the 3′UTR met the threshold of interaction energy for miRNA target pairing. Of these, has-miR-181a and has-miR-26a lost their important binding site with a G substitution and showed a significant difference (p < 0.005) in expression between colon tumor and normal samples (Cummins ). The enhanced or reduced miRNA binding caused by SNP variation may have consequences for the corresponding downregulation or upregulation of mRNA stability and translation (Mishra ; Chen ). Table S1 shows the miRNA sequence and binding capacity for this variant. PANTHER subPSEC scores of less than −3.0 (Pdeleterious >0.5) and a PolyPhen PSIC score difference >2.0 indicate that mutations may probably damage protein function. Based on the PANTHER prediction, which yielded a low subPSEC score (−6.08576) and significantly high Pdeleterious value (0.9563), the C277R variant has a good probability of impairing protein function. PolyPhen analysis showed that this variant also tended to enlarge the protein cavity (PSIC score difference = 3.874), yet a further indication of its potential to impair protein function. CASTp analysis provided a better understanding of the fatal transformation in cavity structure caused by the nonsynonymous SNP (Figure 1A,B). The wild-type cavity (Pocket ID = 40), which has a surface area of 60.9 Å2 and a volume of 42 Å3, is composed of atoms from five residues, namely, Cys277, Gly280, Leu357, His360 and Met362 (Figure 1A). Surprisingly, the replacement of Arg277 with Cys increases the surface area by 55.3 Å2 and results in a greater than two-fold expansion in volume (Pocket ID = 60, surface area = 116.2 Å2, volume = 98.4 Å3). The dramatic change in cavity dimensions in the mutant reflects the recruitment of atoms from an additional seven residues, namely, Arg277, Gly280, Lys281, Asp356, Leu357, His360 and Met362 (Figure 1B).
Figure 1

Functional prediction for the novel nonsynonymous mutation 829T > C in the UGT1A7 gene. (A, B) The Cys277Ary substitution enlarges the cavity configuration as shown by red balls. The pocket ID 40 in the wide-type (A) is formed by atoms from five residues while the pocket ID 60 in the mutant (B) is formed by atoms from seven residues. (C, D) The Cys277Arg substitution alters hydrogen bonds with the surrounding residues as shown by the green dotted line. Cys277 forms hydrogen bonds with Gly280 and Lys281 (C) whereas Arg277 regenerates hydrogen bonds with Lys281, Ile272 and Asp356 (D).

The Cys277Arg substitution disrupts a hydrogen bond with Gly280 on the same helix structure but creates two hydrogen bonds with Ile272 and Asp356, and one between them (Figure 1C, D). The three-dimensional structure of the region shown in Figure 1 indicates that the change in hydrogen bonding can explain the expansion of the pocket. These findings suggest that Cys277, together with Ile272 and Asp356, may act as anchors between two helices to regulate the pocket size during interaction with various drugs. The presence of a highly conserved residue in an important domain, together with the striking alteration in cavity configuration caused by this single amino acid substitution, suggests that the new variant could produce a malfunctioning protein. As shown here, UGT1A7*11 was a common coding variant (41.4%) in Chinese Han, in agreement with previous investigations of Asian populations (35% in 301 Japanese, 39% in 50 Koreans) (Saeki ; Yea ). In contrast, the frequencies of other variants differ considerably among ethnic populations. In Asians, the frequencies of UGT1A1*6 and *27 were reported to range from 7.1% to 21.3% and 0.9% to 5%, respectively (Chen ; Zhou ), whereas these variants were not observed in Caucasians (Thomas ; Borucki ). Among Taiwanese, the frequencies of alleles UGT1A1*2, *27 and *28 were 21.3%, 5.0% and 28.6%, respectively (Tang ), compared with the corresponding value of 18.5%, 1.5% and 10.5% observed here. Similar interethnic differences in frequency exist among Dong, She and Han populations (Zhang ). These differences may partly reflect the fact that some rare variants are unique to certain ethnic groups, but may also be related to the small sample sizes used. In this study, we used 100 subjects and this number may have been too small for adequate LD analysis, particularly since D’ values tend to be higher when small sample sizes or rare alleles are examined. A larger sample size is therefore required to obtain more precise information. Although we have predicted the potential significance of novel variants in Chinese Han, additional studies in vivo and in vitro are required to determine whether these variants cause functional changes in UGT1A. Overall, the special haplotype patterns and htSNPs described here should facilitate genotype-phenotype studies in larger populations.
  36 in total

Review 1.  The predictive power of haplotypes in clinical response.

Authors:  R Judson; J C Stephens; A Windemuth
Journal:  Pharmacogenomics       Date:  2000-02       Impact factor: 2.533

2.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  The role of site accessibility in microRNA target recognition.

Authors:  Michael Kertesz; Nicola Iovino; Ulrich Unnerstall; Ulrike Gaul; Eran Segal
Journal:  Nat Genet       Date:  2007-09-23       Impact factor: 38.330

Review 4.  UDP-glucuronosyltransferases.

Authors:  C D King; G R Rios; M D Green; T R Tephly
Journal:  Curr Drug Metab       Date:  2000-09       Impact factor: 3.731

5.  Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes.

Authors:  Kung-Sheng Tang; Hui-Fen Chiu; Hong-Hwa Chen; Hock-Liew Eng; Chia-Jung Tsai; Hsiu-Chen Teng; Ching-Shan Huang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  UGT1A1 haplotype mutation among Asians in Singapore.

Authors:  Y Y Zhou; L Y Lee; S Y Ng; C P P Hia; K T Low; Y S Chong; D L M Goh
Journal:  Neonatology       Date:  2009-03-27       Impact factor: 4.035

7.  Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers.

Authors:  Katrin Borucki; Cornelia Weikert; Eva Fisher; Sibylle Jakubiczka; Claus Luley; Sabine Westphal; Jutta Dierkes
Journal:  Clin Biochem       Date:  2009-09-02       Impact factor: 3.281

8.  Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

Authors:  Erika Cecchin; Federico Innocenti; Mario D'Andrea; Giuseppe Corona; Elena De Mattia; Paola Biason; Angela Buonadonna; Giuseppe Toffoli
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

9.  Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

Authors:  Jean-François Gagné; Valerie Montminy; Patrick Belanger; Kim Journault; Genevieve Gaucher; Chantal Guillemette
Journal:  Mol Pharmacol       Date:  2002-09       Impact factor: 4.436

Review 10.  Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.

Authors:  John O Miners; Ross A McKinnon; Peter I Mackenzie
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221

View more
  3 in total

Review 1.  Colorectal cancer in Chinese patients: current and emerging treatment options.

Authors:  Leung Li; Brigette By Ma
Journal:  Onco Targets Ther       Date:  2014-10-04       Impact factor: 4.147

2.  Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia.

Authors:  Jie Bai; Lei Luo; Shuang Liu; Chen Liang; Li Bai; Yu Chen; Sujun Zheng; Zhongping Duan
Journal:  Front Genet       Date:  2019-10-31       Impact factor: 4.599

3.  Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.

Authors:  B Ma; A D King; L Leung; K Wang; A Poon; W M Ho; F Mo; C M L Chan; A T C Chan; S C C Wong
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.